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Noradrenaline release frorn rat brain cortical synaptosom,,'S permeabilized with streptolysin 0 can be triggered by,uM conccntrations of free Ca2+. 
This process was inhibited within minutes by tetanus toxin and its isolated light chain, but not by its heavy chain. The data demonstrate that the 
elfect of tetanus toxin on NA release frem purified synaptosomes is caused by thc intraterminal action of its light chain. 
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1. INTRODUCTION 
Tetanus toxin (TeTx), is a hiShly nellrotoxic protein, 
which preferentially blocks neurotransmitter release 
frorn neurons of the central nervous system (cf. [1-3]). 
It is synthesized by Clostridium tetani and consists of 
disulphide-linked heavy (100 kDa) and light chains (50 
kDa) (cf. [3]) [4,5]. 111 contrast to the intact toxin, the 
individual chains alone lack toxicity in vive [6,7]. 
When directly injected into the cytosol, TeTx inhibits 
exocytosis from adrenal chrom affin cells as revealed by 
cell capacitance measurements [8]. Also, in permeabil-
ized adrenal chromaffin cells, pheochromocytoma cells 
(PCI2 cells) [9-11] and neurosecretosomes from the 
posterior pituitary gland [12), TeTx turned out to be a 
potent inhibitor of noradrenaline (NA) and vasopressin 
release. In addition it has been shown that TeTx is more 
effective in these cells in the presence of a reducing 
agent, wh ich causes chain separation [9,10,12]. Indeed, 
the ability of TeTx to inhibit release of catecholamines 
[10,13] and vasopressin [12) was found to be confined 
to the light chain subunit of this protein. Microinjection 
of TeTx and its isolated chains or of mRNA encoding 
tor TeTx light chain in ganglia of Ap/ysia ca/ijornica, 
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allowed to extend these findings to invertebrate neurOl1~ 
[14,15). In contrast, amylase release from streptolysin 0 
(SLO)-permeabilized pancreatic acinar cells is insensi-
tive to TeTx and its light chains [16). 
Taken together the available data suggest that exocy-
tosis from endocrine cells, endocrine nerve endings and 
invertebrate neurons but not from exocrine cells is 
blocked by the light chain of TeTx. However, the intra-
cellular effect ofTeTx on neurotransmitter release from 
neurons of the mammalian central nervous system, the 
targets in TeTx-induced neuroparalytic diseases, was 
not studied to date. 
SLORpermeabilized synaptosomes release NA upon 
addition of Ca2oj• in ,uM concentrations [17-19). This 
preparation is suitable to introduce macromolecules 
into the presynaptic terminal, since antibodies against 
the intrasynaptosomal pro tein kinase C substrate B-50 
inhibit Ca2+ -induced NA release as weil a!1 B-50 phos-
phorylation [18,19]. In the present study we used this 
preparation to study the intraterminal effect of TeTx 
and its isolated chains on Ca2.,. Rinduced NA release. 
2. MATERIALS AND METHODS 
2.1. MCIlerla/s 
Tetanus toxin was separated into its heavy and light chains by 
isoelectric focusing in a sucrose gradient witl! ampholyte und er reduc-
ins conditions in 2 molll uren [20]. Berore use, all toxin preparalion$ 
were dialyzed against thc following buffer: !39 ruM potassium gluta-
mate, 20 mM PIPES, 5 mM EGT A, I mM MgCI2, pR 6.5. 
L.[7,8-l H]noradrenaline (specific activily 34 Ci/mrno!) was pur-
chased from Amersh:m: {Bucklnghamstüre, UK). PercoU was ob-
tained from Pharmacia (Uppsala, Sweden), ATP from Boehringer 
(Mannheim, Oermany), SLO from Wellcome (Weesp, The Nether-
lands), EGTA and BSA from Sigma (SI. Louis, USA). 
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2.2. Melhods 
2.2.1. [lH]noradrenaline release rrom SLO-pcrrneabilized synap-
losomes 
S)'naptosomes were prcpared from cercbrocortelt of male WisUlr 
rats (100-120 g) 115 dcscribed [21]. Thc)' wcre incubatcd in ox)'scnated 
buffer A (mM: 123 NaCI, 5 KCI, 2 CaCll , 2 MgCI2, 1.15 NaH2PO~' 
20 PIPES, 5.6 o-(+)-g1ucosc, pH 6.8), labelIed with [3H]NA (~.5 pCiI 
mg synaplosomal protein) and washed as described earlier [18]. 
SYllaptosomes (final concentmtioll: 0.17 mg/mI) w~te permeabilized 
wilh 0.3 lU/mi SLO in buffer A (without CaCl l and MgCIJ in the 
presence of I mg/mI BSA, 2 mM ATP, 10 mM EOTA, 2 mM free 
Ma2<, the indicated concentration of Cal + and lhe TeTlt prcparation 
to be tesleü rut' 5 minutc:; at 37°C (water bath). C~l+/EGTA buffers 
were calculated and prcpared as described [22]. 
Incubations were stopp cd by centrifugation for 25 s at 10,000 x g. 
[lH]NA release was deterrnined by liquid scintillation counting of the 
radioactivity in the supernatallt. NA release is exprcssed ns percentage 
of total [lH]NA incorporalcd. 
2.2.2. Othcr dctcrminations 
Protein concentrations wcre dctermined according to [23] using 
ßSA as a standard. Slatistical analysis was performed with a two-
tailed Stüdent's I-test. A value of P <: 0.05 was considered to be signir-
icant. 
3. RESULTS 
Increasing the free Ca2'" concentration from 10-8 M 
to 10-5 M induced the release of 12% of total [3H)NA 
incorporated by SLO-permeabilized synaptosomes. 
This Ca:!+-induced [3H)NA release was inhibited by ad-
dition of TeTx light chain within 5 minutes of incuba-
tion in a dose-dependent manner (Fig. I, ICso about 300 
nM). lncubation with 100, 300 and 1000 nM light chain 
led to 9%, 30% and 48% inhibition of Ca:!'" -indu,X'd NA 
release, respectively. The basal [3H)NA release (in the 
presence of 10-8 M Ca:!+) was not significantly affected 
up to 300 nM LC. 1000 nM light chain caused a slight 
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FiS· 1. Effcct of TeTx light chain on [lH]NA release from SLO-
pcrrneabilized synaptosomes. Synllptosomes were perrneabilizcd witb 
0.3 lU/mI SLO in the prcsence of IO-H M Cal " (open circles) or 10-5 
M Ca2< (filIed circles) for 5 minutes at 37·C. The indicated concentm-
t::ms of T::T~ light ehain were presem throughout the experiment 
(ab5Ciss~). [lH]NA release was measured as described (see Methods) 
and is expresscd as percentage of total [3H]NA incorpofated (ordi-
nale). Data are means ± SEM of 12-24 determinations obtained from 
four independent cltperiments. 
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Fig. 2. Effect orTeTx and its isolated light and heavy chain on [lH]NA 
release from SLO-permeabilizcd synapto50mes. Synllpto50mes wcre 
perrneabilized with 0.3 lU/mI SLO in the presence of IO-H M Ca2. 
(open bars) or 10-' M Ca:+ (filIed bars) for 5 minutes at 37·C. 
Throl1ghout thc experiment, either no toxin (e) or TeTx, its light (L) 
or heav)' chains (H) were pre:;ent each at 1000 nM. [lH]NA relca:;e is 
expressed as percentagc oftotal [lH]NA incorporated (ordinate). Data 
are means :t SEM of 6-18 detcnninations obtained from three inde-
pendent experiments. 
chain form) was less active when compared to the effect 
of its light chain (Fig. 2). Tbe inhibitory effect ofTeTx 
and its light chain was abolished by boiling (not shown). 
Isolated TeTx heavy chains lacked any effect (Fig. 2). 
4. DISCUSSION 
A three step-model for the action of clostridial neuro~ 
toxins such as TeTx and botulinum A toxin (BoNTI A) 
has been suggested (cf. [3,24,25)). The three steps in-
volve (i) binding of the toxins to the cell surface via the 
heavy chain, (ii) internalization and transfer to the cyto-
plasm and (iii) inhibition of a Ca2+ -dependent step in 
exocytosis by the light cbain. Using intact cell prepara-
tions, the intracellular action of clostridial neurotoxins 
could not directly be investigated. The direct intracellu-
lar application of the toxins and their fragments in nor~ 
mal or neoplastic chromaffin cells via a patch clamp 
pipette [8] or by pemleabilization of tbe plasma mem-
brane [9,10,13,26-29] allowed to demonstrate that tox-
icity is confined to the light chains of both, TeTx and 
BoNT/A and that the toxins act at a 5tep downstream 
of the action of Ca2+ during exocytosis. 
In this study we investigated for the first time the 
intraterminal effects ofTeTx in endings from the mam-
malian central nervous system. We used a SLO-permea-
bilized synaptosome preparation, which has been 
shown to release NA in a Ca:!+-dependent manner [17-
19]. With tbis prepäi'ation, which is suitable to intro-
duce macromolecules without affecting the release ma-
chinery [19,30], we show that tbe TeTx light chain inhib-
its Ca:!+ -induced NA release. The inhibitory effect oftbe 
light chain is observed within 5 mimnes. Since signm-
cant penneabilization with SLO can be observed after 
about 1 minute [18] and NA release iscomplete in ahout 
3 minutes (Hens and De Graan, unpublished), the effect 
of the light chain probably occurs within 3 minutes. 
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The results are consistent with the observed short 
time required for the action of TeTx light chain in per-
meabilized neurosecretosomes from the posterior pitui-
tary gland [12] and are indicative for a fast intracellular 
action of the TeTx light chain. Intact TeT~ was less 
effective in penneabilized synaptosomes than the iso-
lated light chain. This may indicate that chain separa-
tion, which presumably is an important process during 
TeTx and BoNT/A activation [9,10,12,26,31), by en-
dogenous systems [32], is probably not completed 
within the 5 minutes of iilcubation. 
In contrast to the light chain, the heavy chain alone 
did not inhibit [3H]NA release from SLO-permeabilized 
synaptosomes. Similarly, intracellular application of 
TeTx light chains but not of heavy chains was reported 
to inhibit vasopressin release from neuroseeretosomes 
of the posterior pituitary gland [12], acetylcholine from 
ganglia of Aplysia californlca [14] and NA from adrenal 
chromaffi11 cells [10,13]. 
The above-mentioned results show similarities with 
those reported for BoNT/A, wh ich is in many respects 
very similar to TeTx (cf. [1-3)). In normal or neoplastic 
chromaffin cells as weil as in neurohypophyseal nerve 
endings, only the light chain, but not the heavy chain 
of BoNT/A inhibits exocytosis [27-29,31]. However, 
when injected into Aplysia neurons, the isolated light 
chain of BoNT/A, has no effect. In these neurons both 
the heavy and the light chains must be simultaneollsly 
present to inhibit transmitter release [33,34]. The intra-
eellular effeet of BoNT/A and its isolated chnins on 
synapses of the eentral nervous system has yet not been 
investigated. It will be interesting to see, whether the 
light chain alone will hnve any effect in this system or 
whether, in analogy to invertebrate neurons, the pres· 
ence of the heavy chain is required. 
In summary, our data show that the light chain of 
tetanus toxin alone inhibits transmitter release from 
permeabilized rat brain synaptosomes. They support 
previolls investigations carried out with adrenal ehro-
maffin cells, nerve endings from the posterior pituitary 
gland Bild invertebrate gangHa and extend them to neu-
rons of the centr~l nervous syst~m being struetures di-
reetly involved in tetanus toxin-induced disease. 
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